| ACE | Angiotensin-converting enzyme |
| ACE2 | Angiotensin-converting enzyme 2 |
| AD | Atopic dermatitis |
| Ang II | Angiotensin II |
| ANOVA | Analysis of variance |
| APP | Aminopeptidase P |
| AT1R, AT2R | Angiotensin receptor 1 and 2 |
| BK | Bradykinin |
| BMI | Body mass index |
| COVID-19 | Coronavirus disease 2019 |
| CPN, CPB2 | Carboxypeptidases N and B2 |
| CRPS | Complex Regional Pain Syndrome |
| DBK or DBK1-9 | Dabsylated bradykinin |
| DBK1-5, DBK1-8 | Enzymatic fragments of DBK |
| HEPES | 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethansulfonic acid |
| hPOP | human Personal Omics Profiling, international consortium “Community-Based Personalized Omics Profiling to Assess the Population’s Omics Variation and Dynamics” |
| HUPO | Human Proteome Organisation |
| KKS | Kinin–kallikrein system |
| NIST | National Institute for Standards and Technology |
| NRA | Neuropeptide reporter assay |
| PCA | Principle components analysis |
| RAS | Renin–angiotensin system |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| Std. Dev. | Standard deviation |
| TLC | Thin-layer chromatography |